Ketamine, SGB and Combination Treatment for TBI

PHASE2RecruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

April 30, 2028

Conditions
Posttraumatic HeadachePosttraumatic Stress Disorder
Interventions
PROCEDURE

Group A active comparator

Group A placebo comparator. Stellate Ganglion Block plus placebo (.9 normal saline) infusion

DRUG

Group B active comparator

Active Comparator: Group B = Sham Stellate Ganglion Block plus ketamine infusion

COMBINATION_PRODUCT

Group C Experimental

Group C experimental Stellate Ganglion Block plus ketamine infusion

OTHER

Group D Placebo Comparator

Group D Placebo Comparator: Sham Stellate Ganglion Block plus placebo normal saline

Trial Locations (3)

20889

NOT_YET_RECRUITING

Walter Reed National Military Medical Center, Bethesda

28310

NOT_YET_RECRUITING

Womack Army Medical Center, Fort Bragg

60611

RECRUITING

Anesthesiology Pain Medicine Center, Chicago

All Listed Sponsors
collaborator

Walter Reed National Military Medical Center

FED

collaborator

Lviv National Medical University

OTHER

collaborator

Womack Army Medical Center

FED

lead

Northwestern University

OTHER

NCT06608277 - Ketamine, SGB and Combination Treatment for TBI | Biotech Hunter | Biotech Hunter